Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oxazolidines as 5-HT2A-antagonists

Oxazolidines as 5-HT2A-antagonists

US Patent 6462056 · Granted Oct 8, 2002

Estimated economic value: $215,448,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-y2017
Bicyclic heteroaromatic compounds2016
Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-y2015
Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-y2014
Pyrimidine derivatives as FAK inhibitors2014
Azaheterocyclic compounds as kinase inhibitors2014
4-(2-(6-substituted-hexylidene) hydrazinyl)benzonitrile and preparation thereof2014
Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-y2014
Imidazothiadiazole derivatives2013
Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-y2012
Polymorphic forms of 1-′4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl2012
5-cyanothienopyridines for the treatment of tumours2012